<<
  • Company Research (226)
  • Pharmaceuticals (226)

We found 226 reports

Showing: 161 - 180 of 226 reports
<< previous  3  4  5  6  7  8  9  10  11  12  next >>
Desc
Manta  Respironics, Inc. SWOT Analysis and Company Profile
The company recorded revenues of $1,195 million during the fiscal year ended June 2007, an increase of 14.2% over 2006. The operating profit of the company was $174.8 ...
Publisher:  Datamonitor
10-03-2007 $125.00
Manta  ALK-Abello SWOT Analysis and Company Profile
The company recorded revenues of DKK1,489 million* (approximately $256.2 million) during the fiscal year ended August 2006, an increase of 22.4% over 2005. The operating profit of the ...
Publisher:  Datamonitor
09-14-2007 $125.00
Manta  Alliance Boots Plc SWOT Analysis and Company Profile
AU recorded revenues of £9,171.2 million during the fiscal year ended December 2005, an increase of 3.1% over 2004. Boots recorded revenues of £5,471.2 million during the fiscal year ...
Publisher:  Datamonitor
09-05-2007 $125.00
Manta  UCB SA SWOT Analysis and Company Profile
The company recorded revenues of E2,523 million during the fiscal year ended December 2006, an increase of 7.8% over 2005. The operating profit of the company was E571 million ...
Publisher:  Datamonitor
08-24-2007 $125.00
Manta  Co-operative Group (CWS) Limited SWOT Analysis and Company Profile
The company recorded revenues of £7,271 million during the fiscal year ended December 2006, an increase of 14.3% over fiscal year ended December 2006. The operating profit of the ...
Publisher:  Datamonitor
07-30-2007 $125.00
Manta  Tercica Inc SWOT Analysis and Company Profile
The company recorded revenues of $1.5 million in 2006. The company did not report any revenues during 2005, as it began commercializing Increlex, the sole marketed product, only in ...
Publisher:  Datamonitor
07-14-2007 $125.00
Manta  Depomed Inc SWOT Analysis and Company Profile
The company recorded revenues of $9.6 million during the fiscal year ended December 2006, compared to the revenues of $4.4 million in 2005. The operating loss of the company ...
Publisher:  Datamonitor
06-21-2007 $125.00
Manta  Salix Pharmaceuticals,Ltd. SWOT Analysis and Company Profile
The company recorded revenues of $208.5 million during the fiscal year ended December 2006, an increase of 34.8% over 2005. The operating profit of the company was $30.3 million ...
Publisher:  Datamonitor
06-19-2007 $125.00
Manta  Pharmion Corporation SWOT Analysis and Company Profile
The company recorded revenues of $238.6 million during the fiscal year ended December 2006, an increase of 7.9% over 2005. The operating loss of the company was $90.2 million ...
Publisher:  Datamonitor
06-15-2007 $125.00
Manta  Kyowa Hakko Kogyo Co., Ltd. SWOT Analysis and Company Profile
The company recorded revenues of JPY354,200 million (approximately $3,004.1 million) during the fiscal year ended March 2007, an increase of 0.2% over 2006. The operating profit of the company ...
Publisher:  Datamonitor
06-13-2007 $125.00
Manta  Astellas Pharma - SWOT Analysis and Company Profile
Astellas Pharma (Astellas) is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company primarily operates in Japan and is headquartered in Tokyo, Japan ...
Publisher:  Datamonitor
05-31-2007 $125.00
Manta  Dainippon Sumitomo Pharma Co., Ltd. - SWOT Analysis and Company Profile
Dainippon Sumitomo Pharma (DSP) manufactures, sells, purchases, imports and exports pharmaceuticals, diagnostics, medical devices, veterinary products, food additives, industrial chemicals, and other chemical products. The company primarily operates in ...
Publisher:  Datamonitor
05-31-2007 $125.00
Manta  Tanabe Seiyaku Co. Ltd - SWOT Analysis and Company Profile
Tanabe Seiyaku (Tanabe) is primarily engaged in the research, development, manufacture and sale of pharmaceuticals, including ethical drugs, over-the-counter (OTC) drugs and diagnostics. Its pharmaceutical products include Remicade, Herbesser, ...
Publisher:  Datamonitor
05-31-2007 $125.00
Manta  Daiichi Sankyo, Ltd. - SWOT Analysis and Company Profile
Daiichi Sankyo is a joint holding company for Daiichi Pharmaceutical Company (Daiichi) and Sankyo Company. The company is engaged in the discovery, development, manufacturing and marketing of prescription drugs, ...
Publisher:  Datamonitor
05-30-2007 $125.00
Manta  Merck KGaA - SWOT Analysis and Company Profile
Merck KGaA (Merck) is a global pharmaceutical and chemicals company. The company offers prescription and patented drugs, and chemicals for high-tech applications. The company operates in 54 countries spanning ...
Publisher:  Datamonitor
05-30-2007 $125.00
Manta  Rite Aid Corporation - SWOT Analysis and Company Profile
Rite Aid is a retail drugstore chain operator engaged in the sale of prescription drugs and other merchandise. It operates drug stores in 27 states across the US and ...
Publisher:  Datamonitor
05-30-2007 $125.00
Manta  AstraZeneca PLC - SWOT Analysis and Company Profile
AstraZeneca is a leading pharmaceutical company that discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare, such as cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and ...
Publisher:  Datamonitor
05-25-2007 $125.00
Manta  Purdue Pharma - SWOT Analysis and Company Profile
Purdue Pharma (Purdue) and its independent associated US companies are pharmaceutical companies conducting pioneering research on persistent pain. The company is engaged in the research, development, production, and distribution ...
Publisher:  Datamonitor
05-24-2007 $125.00
Manta  ALZA Corporation - SWOT Analysis and Company Profile
Alza Corporation (Alza), a subsidiary of Johnson & Johnson, is a provider of drug delivery solutions with an array of technology platforms, including oral, transdermal, implantable and liposomal technologies. ...
Publisher:  Datamonitor
05-21-2007 $125.00
Manta  Allergan, Inc. - SWOT Analysis and Company Profile
Allergan is a global health care company engaged in discovery, development and commercialization of specialty pharmaceutical and medical device products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast ...
Publisher:  Datamonitor
05-21-2007 $125.00
 
Showing: 161 - 180 of 226 reports
<< previous  3  4  5  6  7  8  9  10  11  12  next >>